Airway inflammation in asthma and its consequences: Implications for treatment in children and adults

Journal of Allergy and Clinical Immunology

Volumn 109, Issue 6 SUPPL., 2002, Pages

  Djukanovic, Ratko ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Airway inflammation; Airway remodeling; Asthma; Eosinophilia

Indexed keywords

ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ADULT; ADULT DISEASE; ASTHMA; CHILD; CHILDHOOD DISEASE; CHRONIC DISEASE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; HUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; REVIEW;

EID: 0036285931     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.124568     Document Type: Article

References (80)

1. Asthma: From bronchoconstruction to airways inflammation and remodeling
2. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
3. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response
4. Eosinophilis in asthma and other allergic diseases
5. Prednisolone treatment in asthma: Reduction in the numbers of eosinphils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cykokine gene expression within the bronchial mucosa
6. The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation
7. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma
8. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics
9. The relationship between airways inflammation and asthma severity
10. Mucosal inflammation in severe glucocorticoid-dependent asthma
11. Bronchoscopic evaluation of severe asthma: Persistent inflammation associated with high dose glucocorticoid
12. Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma
13. The trials and tribulations of IL-5, eosinophils, and allergic asthma
14. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis
15. Treatment of allergic asthma with monoclonal anti-IgE antibody: RhuMAb-E25 Study Group
16. Oral Montelukast, inhaled beclomethasone, and placebo for chronic asthma: A randomized, controlled trial
17. Correlation of bronchial eosinophil and mast cell activation with bronchial hyperresponsiveness in children with asthma
18. Persistent wheezing in very young children associated with lower respiratory inflammation
19. Persistence of sputum eosinophilia in children with controlled asthma when compared with healthy children
20. Noninvasive assessment of airway inflammation in children: Induced sputum, exhaled nitric oxide, and breath condensate
21. Pattern of airway inflammation and its determinants in children with acute severe asthma
22. Bronchoalveolar mast cells in extrinsic asthma: A mechanism for the initiation of the antigen specific bronchoconstruction
23. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: Relationship to bronchial hyperreactivity
24. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway
25. Histamine release from bronchoalveolar lavage cells from asthmatic subjects after allergen challenge and relationship to the late asthmatic response
26. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness
27. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction
28. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics: Cellular, mediator, and permeability changes
29. Sodium cromoglycate in childhood asthma
30. Effect of inhaled H1 and H2 receptor antagonist in normal and asthmatic subjects
31. Comparison of the effects of histamine H1- and H2-receptor agonists on large and small airways in normal and asthmatic subjects
32. H2 receptor blockade and bronchial hyperreactivity to histamine in asthma
33. The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5′ monophosphate in atopic asthma
34. Bronchodilator action of the anti-histaminic terfenadine
35. Treatment of bronchial asthma with terfenadine: A randomized controlled trial
36. What are the candidate groups for pharmacotherapeutic intervention to prevent asthma? ETAC Study Group: Early Treatment of the Atopic Child
37. Mast cell tryptase is a mitogen for epithelial cells: Stimulation of IL-8 production and intercellular adhesion molecule-1 expression
38. Mast cell tryptase stimulates the synthesis of the type 1 collagen in human lung fibroblasts
39. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: Tryptase induces expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells
40. Cell infiltration, ICAM-1 expression, and eosinophil chemotactic activity in asthmatic sputum
41. The long-acting beta2-agonist salmeterol xinafoate: Effects on airway inflammation in asthma
42. Mast cell tryptase and histamine concentrations in bronchoalveolar lavage fluid from patients with interstitial lung disease
43. Elevated histamine and tryptase levels in smokers' bronchoalveolar lavage fluid: Do lung mast cells contribute to smokers' emphysema?
44. Effect of inhaled APC 366 on allergen-induced bronchoconstriction and airway hyperresponsiveness to histamine in atopic asthmatics
45. Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma
46. Human mast cells and basophils: Structure, function, pharmacology, and biochemistry
47. Release of prostaglandin D2 into human airways during acute antigen challenge
48. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
49. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid: Allen and Hanburys Limited UK Study Group
50. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma: The Dutch Asthma Study Group
51. Bronchial eosinophilic infiltration in Crohn's disease in the absence of pulmonary disease
52. Epithelial-mesenchymal interactions in the pathogenesis of asthma
53. Epithelial desquamation in asthma
54. Damage of the airway epithelium and bronchial reactivity in patients with asthma
55. Ciliated cell damage in the bronchial epithelium of asthmatics and non-asthmatics
56. The site of disruption of the bronchial epithelium in asthmatic and non-asthmatic subjects
57. TGF-beta stimulation and inhibition of cell proliferation: New mechanistic insights
58. Cytokine signaling in lung: Transforming growth factor-beta secretion by lung fibroblasts
59. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma
60. Release of transforming growth factor-beta (TGF-beta) and fibronectin by alveolar macrophages in airway diseases
61. Cytokines of the lung
62. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis
63. Involvement of the epidermal growth factor receptor in epithelial repair in asthma
64. Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway
65. Growth factors accelerate epithelial repair in sheep trachea
66. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung
67. Altered [125I] epidermal growth factor binding and receptor distribution in psoriasis
68. Growth factors in wound healing
69. Cell proliferation in the bronchial mucosa of asthmatics and chronic bronchitis
70. Growth factors secreted by bronchial epithelial cells control myofibroblast proliferation: An in vitro co-culture model of airway remodeling in asthma
71. Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma
72. Effect of natural allergen exposure during the grass pollen season on airways inflammatory cells and asthma symptoms
73. Asthma: A disease of inflammation and repair
74. Allergin-induced release of T lymphocyte chemotactic activity from bronchial explants: Differences between mild and steroid-dependent asthma
75. Production of IL-8 and IL-4 by positively and negatively selected CD4+ and CD8+ human T cells following a four-step cell separation method including magnetic cell sorting (MACS)
76. The pathology of asthma with special reference to changes in the bronchial mucosa
77. On the functional consequences of bronchial basement membrane thickening
78. Increased vascularity of the bronchial mucosa in mild asthma
79. Bronchial angiogenesis in severe glucocorticoid-dependent asthma